je.st
news
Home
› AstraZeneca And Isis Pharmaceuticals To Discover And Develop Antisense Drugs For Cardiovascular, Metabolic And Renal Diseases
AstraZeneca And Isis Pharmaceuticals To Discover And Develop Antisense Drugs For Cardiovascular, Metabolic And Renal Diseases
2015-08-04 03:27:28| drugdiscoveryonline News Articles
Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) and AstraZeneca today announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases.
Tags: develop
discover
drugs
diseases
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||